Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: A retrospective, case-controlled study. Clinical article

Journal of Neurosurgery

Volumn 115, Issue 4, 2011, Pages 730-736

  Lin, Ning ^a,b   Dunn, Ian F ^a,b   Glantz, Michael ^c   Allison, Dana L ^d   Jensen, Randy ^d   Johnson, Mark D ^a,b   Friedlander, Robert M ^a,b,f   Kesari, Santosh ^e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d UNIVERSITY OF UTAH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Intrathecal chemotherapy; Leptomeningeal metastasis; Neoplastic meningitis; On off valve; Oncology; Ventriculoperitoneal shunt

Indexed keywords

CYTARABINE; STEROID; THIOTEPA; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BRAIN TUMOR; BRAIN VENTRICLE PERITONEUM SHUNT; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURVIVAL; CASE CONTROL STUDY; CEREBROSPINAL FLUID SHUNTING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYDROCEPHALUS; KARNOFSKY PERFORMANCE STATUS; MALE; MENINGITIS; MULTIMODALITY CANCER THERAPY; NEOPLASTIC MENINGITIS; NEUROLOGICAL COMPLICATION; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RESERVOIR; RETROSPECTIVE STUDY; SEIZURE; SYMPTOM; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INJECTIONS, SPINAL; MALE; MENINGEAL CARCINOMATOSIS; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VENTRICULOPERITONEAL SHUNT;

EID: 80053394908     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2011.5.JNS101768     Document Type: Article

References (28)

1. Berger MS, Baumeister B, Geyer JR, Milstein J, Kanev PM, LeRoux PD: The risks of metastases from shunting in children with primary central nervous system tumors. J Neurosurg 74:872-877, 1991
2. Bernstein WB, Kemp JD, Kim GS, Johnson VV: Diagnosing leptomeningeal carcinomatosis with negative CSF cytology in advanced prostate cancer. J Clin Oncol 26:3281-3284, 2008
3. Bokstein F, Lossos A, Siegal T: Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy. Cancer 82:1756-1763, 1998 (Pubitemid 28208928)
4. Boogerd W, van den Bent MJ, Koehler PJ, Heimans JJ, van der Sande JJ, Aaronson NK, et al: The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study. Eur J Cancer 40:2726-2733, 2004 (Pubitemid 39574724)
5. Brem SS, Bierman PJ, Brem H, Butowski N, Chamberlain MC, Chiocca EA, et al: Central nervous system cancers. J Natl Compr Canc Netw 9:352-400, 2011
6. Bruna J, González L, Miró J, Velasco R, Gil M, Tortosa A: Leptomeningeal carcinomatosis: prognostic implications of clinical and cerebrospinal fluid features. Cancer 115:381-389, 2009
7. Bruno MK, Raizer J: Leptomeningeal metastases from solid tumors (meningeal carcinomatosis). Cancer Treat Res 125:31-52, 2005
8. Chamberlain MC, Glantz M: Ventriculoperitoneal shunt in patients with leptomeningeal metastasis. Neurology 66:783, 2006 (Pubitemid 43739857)
9. Chowdhary S, Chamberlain M: Leptomeningeal metastases: current concepts and management guidelines. J Natl Compr Canc Netw 3:693-703, 2005 (Pubitemid 44265414)
10. DeAngelis LM, Boutros D: Leptomeningeal metastasis. Cancer Invest 23:145-154, 2005 (Pubitemid 40463913)
11. DeAngelis LM, Posner JB (eds): Leptomeningeal metastases, in Neurologic Complications of Cancer, ed 2. New York: Oxford University Press, 2008, pp 240-274
12. Drappatz J, Batchelor TT: Leptomeningeal neoplasms. Curr Treat Options Neurol 9:283-293, 2007
13. Glantz MJ, Hall WA, Cole BF, Chozick BS, Shannon CM, Wahlberg L, et al: Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status. Cancer 75:2919-2931, 1995
14. Glantz MJ, Jaeckle KA, Chamberlain MC, Phuphanich S, Recht L, Swinnen LJ, et al: A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res 5:3394-3402, 1999
15. Grossman SA, Finkelstein DM, Ruckdeschel JC, Trump DL, Moynihan T, Ettinger DS: Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group. J Clin Oncol 11:561-569, 1993 (Pubitemid 23071056)
16. Grossman SA, Trump DL, Chen DC, Thompson G, Camargo EE: Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis. An evaluation using 111indium-DTPA ventriculography. Am J Med 73:641-647, 1982 (Pubitemid 13234217)
17. Harstad L, Hess KR, Groves MD: Prognostic factors and outcomes in patients with leptomeningeal melanomatosis. Neuro Oncol 10:1010-1018, 2008
18. Hitchins RN, Bell DR, Woods RL, Levi JA: A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol 5:1655-1662, 1987 (Pubitemid 18010143)
19. Kesari S, Batchelor TT: Leptomeningeal metastases. Neurol Clin 21:25-66, 2003 (Pubitemid 36169344)
20. Mason WP: Leptomeningeal metastases, in Schiff D, Wen PY (eds): Cancer Neurology in Clinical Practice. Totowa: Humana Press, 2003, p 115
21. Melisko ME, Glantz M, Rugo HS: New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer. Nat Clin Pract Oncol 6:25-33, 2009
22. Omuro AM, Lallana EC, Bilsky MH, DeAngelis LM: Ventriculoperitoneal shunt in patients with leptomeningeal metastasis. Neurology 64:1625-1627, 2005 (Pubitemid 40617704)
23. Pace A, Fabi A: Chemotherapy in neoplastic meningitis. Crit Rev Oncol Hematol 60:194-200, 2006 (Pubitemid 44709621)
24. Pavlidis N: The diagnostic and therapeutic management of leptomeningeal carcinomatosis. Ann Oncol 15 (Suppl 4):iv285-iv291, 2004
25. Sandberg DI, Bilsky MH, Souweidane MM, Bzdil J, Gutin PH: Ommaya reservoirs for the treatment of leptomeningeal metastases. Neurosurgery 47:49-55, 2000 (Pubitemid 32047762)
26. Wasserstrom WR, Glass JP, Posner JB: Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 49:759-772, 1982 (Pubitemid 12165435)
27. Yoshida S, Morii K: Intrathecal chemotherapy for patients with meningeal carcinomatosis. Surg Neurol 63:52-55, 2005 (Pubitemid 40082435)
28. Zada G, Chen TC: A novel method for administering intrathecal chemotherapy in patients with leptomeningeal metastases and shunted hydrocephalus: case report. Neurosurgery 67 (3 Suppl Operative):onsE306-onsE307, 2010